Inventor
SCOTT D. LARSEN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry15%
C07CAcyclic or carbocyclic compounds15%
PatentTitleYear
12,390,434Compositions and methods for reducing immune intolerance and treating autoimmune disorders202512,016,836Compositions and methods for reducing immune intolerance and treating autoimmune disorders202411,944,626Small molecule inhibitors of ALDH and uses thereof202411,648,225Compositions and methods for reducing immune intolerance and treating autoimmune disorders202311,220,479Glucosylceramide synthase inhibitors and therapeutic methods using the same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to UNIV MICHIGAN REGENTS (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to LAPIX THERAPEUTICS INC (3)· patent assignee history
2024Patents assigned to UNIV INDIANA RES & TECH CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LAPIX THERAPEUTICS INC | 3 | 2023–2025 |
| UNIV MICHIGAN REGENTS | 2 | 2022–2024 |
| UNIV INDIANA RES & TECH CORP | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |